H-1B sponsorship profile: Lyndra Therapeutics, Inc. Across U.S. Department of Labor LCA disclosures, Lyndra Therapeutics, Inc filed 5 Labor Condition Applications covering 5 H-1B worker positions between fiscal year 2023 and fiscal year 2025. The employer’s DOL certification rate sits at 100% (5 certified of 5 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Lyndra Therapeutics, Inc’s H-1B petitions range from $101,000 at the low end to $320,190 at the high end, with a petition-weighted average of $159,045. That range reflects the mix of occupations the company sponsors, led by VP, Clinical Development (1 petitions at $320,190 avg), followed by Senior Manager/Associate Director, CMC Project Management and Scientist I, Process Development. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Lyndra Therapeutics, Inc is headquartered in Watertown, MA under NAICS code 32541, and places H-1B workers across 3 states, most heavily in MA, NJ, TX. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Lyndra Therapeutics, Inc ranks. By H-1B petition volume, Lyndra Therapeutics, Inc is #26,547 of 119,880 employers nationally and #1,208 of 5,193 employers headquartered in MA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.